Kidney Transplantation
📧 Sign up to get email alerts when something new happens for Kidney Transplantation.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-09-28FDA Approved: TACROLIMUS — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for tacrolimus by Accord Healthcare Inc., expanding the availability of a generic tacrolimus product…
-
CLINICAL_TRIALS research · 2015-09-28Clinical Trial Update: Effect of BM-MSCs in DCD Kidney Transplantation [Phase 1, Phase 2]
A clinical trial update on the use of bone marrow-derived mesenchymal stem cells (BM-MSCs) in donation-after-cardiac-death kidney transplant…
-
CLINICAL_TRIALS trial_result · 2015-09-10Clinical Trial Update: Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily [Phase 3]
Phase 3 clinical trial update evaluating the safety and efficacy of once-daily LCP-Tacro in stable kidney transplant recipients converted fr…
-
CLINICAL_TRIALS trial_result · 2015-09-02Clinical Trial Update: Validation of a Novel Diagnostic Tool for the Evaluation of Post Renal Transplant Immunosuppression: The ImmuKnow Assay
A completed validation study evaluating the ImmuKnow assay as a diagnostic tool to assess immunosuppression in kidney transplant recipients.
-
CLINICAL_TRIALS trial_result · 2015-09-01Clinical Trial Update: Advagraf/Prograf Conversion Trial [Phase 4]
A Phase 4 trial evaluating conversion from Prograf to Advagraf in renal and kidney-pancreas transplant patients has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-08-26Clinical Trial Update: Conventional Laparoscopic Versus Laparoendoscopic Single Site Donor Nephrectomy in Living Donor Kidney Transplantation [NA]
Clinical trial comparing conventional laparoscopic vs. laparoendoscopic single-site donor nephrectomy in living donor kidney transplantation…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients [Phase 4]
Phase 4 trial comparing My-Rept Tablet vs. My-Rept Capsule, each in combination with tacrolimus, in kidney transplant patients; the study ha…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Prospective Single-center Study Evaluating the Central Blood Pressure in Renal Transplantation [NA]
A prospective, single-center study evaluating central blood pressure in kidney transplant recipients. The trial status is completed.
-
FDA approval · 2015-08-04FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for MYFORTIC (mycophenolic acid) from Novartis Pharmaceuticals Corporation.
-
CLINICAL_TRIALS trial_result · 2015-08-03Clinical Trial Update: Safety & Tolerability of Berinert® (C1 Inhibitor) Therapy to Prevent Rejection [Phase 1, Phase 2]
Berinert (C1 esterase inhibitor) was studied in Phase 1/2 trials to prevent rejection in kidney transplant recipients. The update reports on…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients [Phase 4]
Phase 4 clinical trial investigating cardiovascular risk profile changes and serum metabolites after conversion from cyclosporine to tacroli…
-
CLINICAL_TRIALS trial_result · 2015-07-13Clinical Trial Update: Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient [Phase 2]
Phase 2 extension study evaluating prevention of acute rejection in kidney transplant patients; results have been posted.
-
FDA approval · 2015-07-10FDA Approved: ENVARSUS XR — Original Application (Veloxis Pharmaceuticals, Inc)
ENVARSUS XR (tacrolimus) received FDA approval as an original application to prevent organ rejection in kidney transplant recipients.
-
CLINICAL_TRIALS research · 2015-07-08Clinical Trial Update: Induction With SVF Derived MSC in Living-related Kidney Transplantation [Phase 1, Phase 2]
This entry reports a Phase 1/Phase 2 clinical trial evaluating induction with SVF-derived mesenchymal stem cells in living-related kidney tr…
-
CLINICAL_TRIALS trial_result · 2015-07-07Clinical Trial Update: Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant [Phase 2]
A multicenter, randomized Phase 2 pharmacokinetic study comparing LCP-Tacro to Prograf capsules in de novo adult kidney transplant recipient…
-
CLINICAL_TRIALS trial_result · 2015-06-26Clinical Trial Update: Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation [Phase 3]
A Phase 3 pediatric kidney transplantation trial comparing steroid withdrawal with tacrolimus to a tacrolimus plus mycophenolate mofetil (MM…
-
CLINICAL_TRIALS trial_result · 2015-06-04Clinical Trial Update: Randomized Study to Reduce Calcineurininhibitor Toxicity in Pediatric and Adolescent Kidney Transplant Recipients [Phase 4]
This trial update notes termination of a Phase 4 randomized study aiming to reduce calcineurin-inhibitor toxicity in pediatric and adolescen…
-
CLINICAL_TRIALS research · 2015-06-02Clinical Trial Update: The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea [NA]
A clinical trial evaluating the usefulness of tacrolimus without basiliximab in well-matched living donor kidney transplantation in Korea; c…
-
CLINICAL_TRIALS trial_result · 2015-06-01Clinical Trial Update: Prediction of Medication Compliance Following Renal Transplantation
A completed clinical trial studying predictors of medication adherence after kidney transplantation.
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx [Phase 3]
Phase 3 trial comparing LCP-Tacro (extended-release tacrolimus) to Prograf for prevention of rejection in de novo adult kidney transplant re…
-
FDA approval · 2015-05-28FDA Approved: SIROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for sirolimus submitted by Mylan Pharmaceuticals, granting regulatory approval for changes to th…
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients [Phase 2, Phase 3]
This completed Phase 2/3 clinical trial from Seoul National University Hospital evaluates converting pediatric kidney transplant recipients …
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients [Phase 3]
Phase 3 pharmacokinetic study comparing two oral formulations of tacrolimus in kidney transplant recipients; the trial status is completed.
-
CLINICAL_TRIALS trial_result · 2015-05-19Clinical Trial Update: Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients [Phase 2]
Phase 2 pharmacokinetics study comparing LCP-Tacro once daily with Prograf twice daily tacrolimus in adult de novo kidney transplant recipie…
-
CLINICAL_TRIALS trial_result · 2015-05-15Clinical Trial Update: Pilot Study: Active Video Gaming to Facilitate Physical Activity and Quality of Life in Kidney Transplant Recipients [Phase 1, Phase 2]
This document describes a completed Phase 1/Phase 2 pilot trial evaluating whether active video gaming can increase physical activity and im…